Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Neurotechnologies have come very far in just a few years, and going forward we can expect them to provide new approaches to shed light on brain function and contribute novel therapeutic interventions for clinic use. In basic neuroscience, a diversity of molecular approaches are enabling researchers to track and manipulate the activity of specific neuronal populations in the brain and peripheral nervous systems of freely moving mice. In the clinic, although surgical and small-molecule approaches traditionally have provided treatments for neurological and psychiatric disorders, these remain blunt therapeutic instruments, often accompanied by considerable side effects in return for limited efficacy. Today, electrode arrays allow the recording and stimulation of neurons with a high degree of precision are being engineered to be flexible and soft, injected into deep-brain structures with a syringe, and connected to decoders and actuators. This is opening up new opportunities for restoring lost function that allow control of robotic arms in quadriplegic patients.
Non-invasive stimulation of the brain is being touted to promote health and well-being and for ‘curing’ disease, but the mechanistic underpinnings of the devices remain unclear.
Tissue-like electronic interfaces that form stable long-term interfaces in the brain will enable treatment of chronic neurological and psychiatric diseases.
Anikeeva and colleagues review the state of the art in technologies that enable discoveries of brain function and the development of novel therapeutic approaches.